Immunotherapy drugs are riskier for treatment of cancer patients, study suggests ANI | Updated: Dec 13, 2020 19:24 IST
Washington [US], December 13 (ANI): A study published in the European Heart Journal, found that the risks of heart problems in cancer patients are higher if they are treated with immunotherapy drugs, which can even lead to death from heart attack.
The researchers from Department of Cardiology at Herlev og Gentofte Hospital, Hellerup, Denmark revealed that the patients diagnosed with either lung cancer or malignant melanoma (a type of skin cancer), are treated with immune checkpoint inhibitors such as a programmed cell death-1 (PD1) inhibitors or cytotoxic T-lymphocyte-associated protein-4 (CTLA-4) inhibitors.
Drugs harmful for cancer patients bignewsnetwork.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bignewsnetwork.com Daily Mail and Mail on Sunday newspapers.